Citius Oncology (CTOR) Assets (2022 - 2026)
Citius Oncology (CTOR) posted quarterly Assets of $100.7 million for Q1 2026, up 10.13% year-over-year from $91.4 million in Q1 2025, and down 8.43% quarter-over-quarter from $110.0 million in Q4 2025.
Citius Oncology (CTOR) Assets (2022 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Assets for 5 consecutive years, with $100.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 10.13% year-over-year to $100.7 million; the TTM figure through Mar 2026 stood at $100.7 million (up 10.13% YoY), while the FY2025 annual figure was $100.9 million, up 19.64% from the prior year.
- Assets slipped to $100.7 million in Q1 2026 per CTOR's latest filing, from $110.0 million in the prior quarter.
- Across five years, Assets topped out at $110.0 million in Q4 2025 and bottomed at $47.7 million in Q3 2023.
- Historically, Assets has averaged $78.2 million across 5 years, with a median of $78.5 million in 2023.
- Annual changes were most pronounced in 2024 — Assets retreated 29.57% — and 2025, when it soared 87.84%.
- Citius Oncology's Assets stood at $68.2 million in 2022, then rose by 6.5% to $72.6 million in 2023, then advanced by 24.59% to $90.5 million in 2024, then gained by 21.54% to $110.0 million in 2025, then dropped by 8.43% to $100.7 million in 2026.
- Business Quant data shows CTOR's Assets at $100.7 million in Q1 2026, $110.0 million in Q4 2025, and $100.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 6.18 Bn |
| 10 | Citius Oncology | 81.12 Mn | 81.12 Mn | 1.00 Mn | 112.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.70 Mn |
| Dec 31, 2025 | 109.97 Mn |
| Sep 30, 2025 | 100.94 Mn |
| Jun 30, 2025 | 91.71 Mn |
| Mar 31, 2025 | 91.44 Mn |
| Dec 31, 2024 | 90.48 Mn |
| Sep 30, 2024 | 84.37 Mn |
| Jun 30, 2024 | 49.19 Mn |
| Mar 31, 2024 | 48.68 Mn |
| Dec 31, 2023 | 72.62 Mn |
| Sep 30, 2023 | 47.73 Mn |
| Jun 30, 2023 | 69.85 Mn |
| Mar 31, 2023 | 68.82 Mn |
| Dec 31, 2022 | 68.19 Mn |